Correction to: Clinical Rheumatology

https://doi.org/10.1007/s10067-022-06263-3

The original published version of the above article contained incorrect Key Points. The authors requested to note the following corrected points.

The Key Points of the article should be:

Key Points:

1. HPLC-MS identified increased serum Kyn/Trp ratio in DM patients, which positively correlated with levels of muscle enzymes and inflammatory markers and was downregulated upon treatment.

2. Cox regression analyses identified ln(Kyn/Trp) as an independent prognostic predictor of mortality in DM.

3. Monitoring intrinsic immune regulation function should be considered a potential therapeutic target in DM patients.

Instead of:

Key Points:

1. HPLC–MS identified increased serum Kyn/Trp ratio in DM patients, which positively correlated with levels of muscle enzymes and inflammatory markers and was downregulated upon treatment.

2. More attention to psychological status is needed in RA patients.

3. Cox regression analyses identified ln(Kyn/Trp) as an independent prognostic predictor of mortality in DM.

The original article has been corrected.